Develops therapeutics for inflammatory and immunological conditions.
Dec 2025Revenue $1.31M/yrExpenses $8.85M/yr
No trendCash runway ≈ 3 months from Dec 2025
Figures by year
When will Scinai Immunotherapeutics be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2025, revenue was $1.31M and expenses $8.85M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $1.31M | $8.85M | −$7.54M |
| Dec 2024 | $658K | $9.30M | −$8.64M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.